In this study, to demonstrate that dampening of the TREM-1-mediated inflammation induced by cancer treatment can suppress cancer progression and improve response rate, the anti-tumor efficacy of GF9 and GA31-LPC and its dependence on treatment timing relative to chemotherapy were evaluated in subcutaneous PANC-1 xenograft-bearing athymic nude mice. This evidence concerns the gene TREM1 and cancer.